Effects of Osteopathic Manipulative Medicine on muscle characteristics in Parkinson's disease patients
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
NA · New York Institute of Technology · NCT05884944
This study tests if Osteopathic Manipulative Medicine can improve muscle function and walking in people with Parkinson's disease.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | New York Institute of Technology (other) |
| Locations | 1 site (Old Westbury, New York) |
| Trial ID | NCT05884944 on ClinicalTrials.gov |
What this trial studies
This study investigates how Osteopathic Manipulative Medicine (OMM) affects lower extremity muscle characteristics in patients with Parkinson's disease. Participants will be randomly assigned to either an experimental group receiving OMM or a control group receiving sham treatment. Muscle stiffness, range of motion, and gait will be assessed using specialized equipment before and after the intervention. The goal is to determine if OMM can improve muscle quality, gait, and overall functionality in these patients.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Parkinson's disease, exhibiting a severity of 2-4 on the Hoehn and Yahr Scale, who experience leg pain or gait abnormalities.
Not a fit: Patients with severe fasciculations or other neurological conditions affecting muscle tone and ambulation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the quality of life for patients with Parkinson's disease by improving their mobility and reducing muscle stiffness.
How similar studies have performed: Preliminary results from similar studies suggest that OMM may improve muscle stiffness and relaxation in patients with Parkinson's disease, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease as per a neurologist, a severity of 2-4 on the Hoehn and Yahr (H-Y) Scale * Able to receive OMM * Able to be in a supine and prone position for MyotonPRO measurements * Able to ambulate for gait measurements * Have musculoskeletal complaints of leg pain/cramping or gait abnormalities due to their PD Exclusion Criteria: * Presence of severe fasciculations based on clinical judgment due to interference with measurements * Gait disorders not attributed to PD * Presence of other medical neurologic diagnoses that can affect outcome measures such as muscle tone/stiffness and ambulation (ie stroke, multiple sclerosis)
Where this trial is running
Old Westbury, New York
- NYIT College of Osteopathic Medicine — Old Westbury, New York, United States (RECRUITING)
Study contacts
- Study coordinator: Sheldon Yao, DO
- Email: syao@nyit.edu
- Phone: 516-686-1300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Parkinson Disease, Osteopathy in Diseases Classified Elsewhere, Osteopathic Manipulative Medicine